demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
Oral antidiabetic drugs
DPP-4 inhibitor Abuhasira

0 studies excluded by filtering options 0